Although HERC4 is oncogenically overexpressed in several cancers including lung cancer and breast cancer, it is downregulated during the progress of myelomagenesis from health bone marrow, MGUS, SMM to typical MM (11, 26). This evidence concerns the gene HERC4 and cancer.